Yeast Beta-Glucan Supplementation with Multivitamins Attenuates Cognitive Impairments in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Study Design
- 研究类型
- RCT
- 样本量
- 65
- 持续时间
- 36 weeks
- 干预措施
- Yeast Beta-Glucan Supplementation with Multivitamins Attenuates Cognitive Impairments in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Contro 4 capsules daily, each containing: beta-glucan 250 mg + vitamin D3 3.75 µg + vitamin B6 1.05 mg + zi
- 对照组
- Placebo
- 效应方向
- Positive
- 偏倚风险
- Low
Abstract
This research aimed to examine the potential alleviative effects of beta-glucan administration on fatigue, unrefreshing sleep, anxiety/depression symptoms and health-related quality of life in ME/CFS. A 36-week unicenter, randomized, double-blind, placebo-controlled trial was conducted in 65 ME/CFS patients, who were randomly allocated to one of two arms to receive four capsules each one of 250 mg beta-glucan, 3.75 µg vitamin D3, 1.05 mg vitamin B6, and 7.5 mg zinc (n = 35), or matching placebo including only microcrystalline cellulose as an excipient (n = 30) once daily. The findings showed that the beta-glucan supplementation significantly improved cognitive fatigue (assessed with FIS-40 scores) after the 36-week treatment compared to the baseline (p = 0.0338). Taken together, this study presents the novel finding that yeast-derived beta-glucan may alleviate cognitive fatigue symptoms in ME/CFS. Thus, it offers valuable scientific insights into the potential use of yeast beta-glucan as a nutritional supplement and/or functional food to prevent or reduce cognitive dysfunction in patients with ME/CFS. Further interventions are warranted to validate these findings and also to delve deeper into the possible immunometabolic pathomechanisms of beta-glucans in ME/CFS.
Full Text
Figures
Tables
Table 5
| SF-36 Domains | Baseline | 36-Weeks | |
|---|---|---|---|
| Active arm (n = 29) | |||
| Physical functioning | 38.45 ± 20.49 | 40.17 ± 22.50 | 0.8178 |
| Physical role functioning | 6.03 ± 16.66 | 10.34 ± 20.61 | 0.2020 |
| Bodily pain | 15.93 ± 15.58 | 20.90 ± 18.68 | 0.1468 |
| General health perception | 22.76 ± 14.18 | 21.90 ± 13.19 | 0.5683 |
| Vitality | 12.24 ± 13.53 | 16.55 ± 15.93 | 0.0526 |
| Social role functioning | 32.33 ± 26.63 | 36.64 ± 25.65 | 0.3344 |
| Emotional role functioning | 34.48 ± 46.70 | 28.74 ± 43.39 | 0.1695 |
| Mental health status | 38.21 ± 21.18 | 42.07 ± 22.69 | 0.1393 |
| Placebo (n = 22) | |||
| Physical functioning | 39.32 ± 21.17 | 38.18 ± 20.21 | 0.9243 |
| Physical role functioning | 1.14 ± 5.33 | 4.55 ± 16.61 | 0.3287 |
| Bodily pain | 20.14 ± 19.22 | 23.73 ± 15.33 | 0.1089 |
| General health perception | 25.32 ± 14.49 | 27.36 ± 17.57 | 0.3225 |
| Vitality | 17.27 ± 16.24 | 15.23 ± 12.77 | 0.5847 |
| Social role functioning | 30.68 ± 20.68 | 42.05 ± 22.34 | 0.0131 * |
| Emotional role functioning | 33.33 ± 44.84 | 37.88 ± 45.19 | 0.4797 |
| Mental health status | 38.73 ± 23.11 | 44.73 ± 20.01 | 0.1918 |
References
- Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology J. Clin. Med., 2020
- Gender differences in chronic fatigue syndrome Reumatol. Clin., 2016
- European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe Medicina, 2021
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review Diagnostics, 2019
- Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: All roads lead to Rome Br. J. Pharmacol., 2017
- Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: A community-based cross-sectional study from Spain BMC Public Health, 2019
- Chronic fatigue syndrome and quality of life Patient Relat. Outcome Meas., 2018
- The Conners Continuous Performance Test CPT3TM: Is it a reliable marker to predict neurocognitive dysfunction in Myalgic encephalomyelitis/chronic fatigue syndrome? Front. Psychol., 2023
- Prevalence of and risk factors for severe cognitive and sleep symptoms in ME/CFS and MS BMC Neurol., 2017
- An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome J. Transl. Med., 2021
- Myalgic encephalomyelitis: International Consensus Criteria J. Intern. Med., 2011
- What’s in a name? Systemic exertion intolerance disease Lancet, 2015
- Cognitive Dysfunction in Chronic Fatigue Syndrome: A Review of Recent Evidence Curr. Rheumatol. Rep., 2016
- Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome—A randomized, controlled, double-blind trial Clin. Nutr., 2016
- Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: Disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS Neuroendocrinol. Lett., 2009
- Poor self-reported sleep quality and health-related quality of life in patients with chronic fatigue syndrome/myalgic encephalomyelitis J. Sleep Res., 2018
- Gut inflammation in chronic fatigue syndrome Nutr. Metab., 2010
- A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome Gut Pathog., 2009
- Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: Neuropsychological symptoms and sex comparisons J. Transl. Med., 2018
- Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: Implications for disease-related biomarker discovery Front. Immunol., 2023
- Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS Cell Host Microbe, 2023
- Alterations in Fecal Microbiomes and Serum Metabolomes of Fatigued Patients With Quiescent Inflammatory Bowel Diseases Clin. Gastroenterol. Hepatol., 2021
- The role of the gut microbiome in cancer-related fatigue: Pilot study on epigenetic mechanisms Support. Care Cancer, 2021
- Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters PLoS ONE, 2015
- Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study Diabetes Care, 2018
- beta-glucans: A potential source for maintaining gut microbiota and the immune system Front. Nutr., 2023
- In vitro fermentation of oat and barley derived beta-glucans by human faecal microbiota FEMS Microbiol. Ecol., 2008
- The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications J. Clin. Med., 2021
- The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) Front. Immunol., 2021
- beta-glucan Salecan Improves Exercise Performance and Displays Anti-Fatigue Effects through Regulating Energy Metabolism and Oxidative Stress in Mice Nutrients, 2018
- Effects of Yeast (1,3)-(1,6)-Beta-Glucan on Severity of Upper Respiratory Tract Infections: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Subjects J. Am. Coll. Nutr., 2019
- A beta-Glucan-Based Dietary Fiber Reduces Mast Cell-Induced Hyperpermeability in Ileum From Patients With Crohn’s Disease and Control Subjects Inflamm. Bowel Dis., 2017
- Effects of beta-(1,3-1,6)-D-glucan on irritable bowel syndrome-related colonic hypersensitivity Biochem. Biophys. Res. Commun., 2012
- Effect of beta-glucan, inositol and digestive enzymes in GI symptoms of patients with IBS Eur. Rev. Med. Pharmacol. Sci., 2011
- Evaluation of the association between placental corticotrophin-releasing hormone and postpartum depressive symptoms Psychosom. Med., 2014
- Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome Sci. Rep., 2017
- The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group Ann. Intern. Med., 1994
- Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale Clin. Infect. Dis., 1994
- The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research Psychiatry Res., 1989
- A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population Gen. Hosp. Psychiatry, 2003
- The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): An instrument for measuring clinical results Med. Clin., 1995
- Effects of oat beta-glucan on innate immunity and infection after exercise stress Med. Sci. Sport. Exerc., 2004
- Role of the gut-brain axis in energy and glucose metabolism Exp. Mol. Med., 2022
- The Microbiota-Gut-Brain Axis: Psychoneuroimmunological Insights Nutrients, 2023
- Multi-’omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients Cell Host Microbe, 2023
- Central and Peripheral Fatigue in Physical Exercise Explained: A Narrative Review Int. J. Environ. Res. Public. Health, 2022
- Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome JCI Insight, 2022
- Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2: More in Common Than Not? Chest, 2023
- High fibre breakfast cereals reduce fatigue Appetite, 2001
- Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial Int. J. Mol. Sci., 2016
- Effect of Oat beta-Glucan on Affective and Physical Feeling States in Healthy Adults: Evidence for Reduced Headache, Fatigue, Anxiety and Limb/Joint Pains Nutrients, 2021
- A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy J. Exp. Clin. Cancer Res., 2008
- Sleep depth and fatigue: Role of cellular inflammatory activation Brain Behav. Immun., 2011
- Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials Molecules, 2019
- beta-Glucan Metabolic and Immunomodulatory Properties and Potential for Clinical Application J. Fungi, 2020
- The Microbiota-Gut-Brain Axis Physiol. Rev., 2019
- Three Different Types of beta-Glucans Enhance Cognition: The Role of the Gut-Brain Axis Front. Nutr., 2022
Used In Evidence Reviews
Similar Papers
The Journal of nutrition · 2003
Zinc deficiency, infectious disease and mortality in the developing world.
The British journal of nutrition · 2002
The immune system: a target for functional foods?
Public health nutrition · 2000
The role of vitamins in the prevention and control of anaemia.
Journal of Alzheimer's disease : JAD · 2018
Homocysteine and Dementia: An International Consensus Statement.
European journal of obstetrics, gynecology, and reproductive biology · 2012
Influence of mineral and vitamin supplements on pregnancy outcome.
Seminars in thrombosis and hemostasis · 2000